Amedisys (AMED) PT Raised to $133 at RBC Capital

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Amedisys (AMED) PT Raised to $133 at RBC Capital

Amedisys (AMED) PT Raised to $136 at UBS

March 1, 2019 6:58 AM EST

UBS raised its price target on Amedisys (NASDAQ: AMED) to $136.00 (from $126.00) while maintaining a Neutral rating.

... More

Amedisys (AMED) PT Raised to $140 at Oppenheimer

February 28, 2019 4:17 PM EST

Oppenheimer analyst Michael Wiederhorn raised the price target on Amedisys (NASDAQ: AMED) to $140.00 (from $137.00) while maintaining a Outperform rating.

... More

Amedisys (AMED) PT Lowered to $124 at Craig-Hallum

February 28, 2019 3:52 PM EST

Craig-Hallum analyst Kevin Ellich lowered the price target on Amedisys (NASDAQ: AMED) to $124.00 (from $132.00) while maintaining a Hold rating.

Ellich notes FY19 guidance was lower partially due to CCH integration.

... More